Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Halozyme Therapeutics Inc. sell SVB Leerink LLC

Halozyme Therapeutics Inc.
Start price
€48.64
13.05.25 / 50%
Target price
€42.31
13.05.26
Performance (%)
22.49%
End price
€59.58
14.05.26
Summary
This prediction ended on 14.05.26 with a price of €59.58. The SELL prediction by SVB_Leerink_LLC finished with a performance of 22.49%. SVB_Leerink_LLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Halozyme Therapeutics Inc. 23.124% 23.124% 64.059%
iShares Core DAX® 0.184% 5.072% 8.979%
iShares Nasdaq 100 -0.770% -2.079% 26.437%
iShares Nikkei 225® 0.733% -3.346% 47.887%
iShares S&P 500 -0.166% 0.904% 22.974%

Comments by SVB_Leerink_LLC for this prediction

In the thread Halozyme Therapeutics Inc. diskutieren
Prediction Sell
Perf. (%) 22.49%
Target price 42.314
Change
Ends at 13.05.26

Halozyme Therapeutics, Inc. (NASDAQ: HALO) was downgraded by analysts at Leerink Partners from a "market perform" rating to an "underperform" rating. They now have a $47.00 price target on the stock.
Ratings data for HALO provided by MarketBeat

SVB Leerink LLC 
0
Report Share
13.05.25
In the thread Trading Halozyme Therapeutics Inc.
Prediction Sell
Perf. (%) 22.49%
Target price 42.314
Change
Ends at 13.05.26

Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten

SVB Leerink LLC 
0
Report Share
14.05.26